The self - renewable
capacity of these cells, their ability to differentiate into several
tissue progenitors (
neural, mesenchymal stem cells...), and the possibility to work with mutated cell lines define human stem cells as a good basis for screening compounds libraries in order to discover new potential drugs for monogenic diseases.